// company-profile

Lexeo Therapeutics, Inc. Insider Trading

LXEO

Every SEC Form 4 insider trading filing for Lexeo Therapeutics, Inc. (LXEO) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.

ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Filings93Insiders28
// api This Lexeo Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
curl "https://api.form4api.com/v1/transactions?ticker=LXEO" -H "X-Api-Key: YOUR_API_KEY"

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Lexeo Therapeutics, Inc. insiders bought $0 (11 transactions) and sold $280K (6 transactions).

  • Most active insider: Townsend Richard Nolan with 3 transactions totaling $133K.
  • Largest single sale: $116K by Townsend Richard Nolan on Jul 1, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Lexeo Therapeutics, Inc. as of 2026-06-30

— stable
Total reported AUM
$55.6M
QoQ change
Reporting period
2026-06-30
#1
STATE STREET CORP
CIK 93751
$20.3M
4.4M shares
#2
BlackRock, Inc.
CIK 2012383
$15.4M
3.3M shares
#3
BlackRock, Inc.
CIK 2012383
$8.8M
1.9M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jul 1, 2026Townsend Richard NolanLXEO
Sale
25,947$4.48$116K
Jul 1, 2026Tamayo Louis EdwardLXEO
Sale
4,641$4.49$21K
Jul 1, 2026Otero Jose ManuelLXEO
Sale
4,666$4.48$21K
Jul 1, 2026Bhalla Narinder PalLXEO
Sale
22,306$4.42$99K
Jun 29, 2026Bhalla Narinder PalLXEO
Award
55,000$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →